Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.

Lockheed Martin (LMT) Offers $1.00 Per Share to Acquire Terran Orbital. LIVE QUOTE Shares of Terran popped in its $1.5 billion trading debut in March of...

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so bold, we might even call it...

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not updated were...

Adial Pharma (ADIL). Why Quit Drinking When You Can Just Cut Back.

"ONWARD™ showed promising results in reducing heavy drinking in heavy drinking patients, and no overt safety or tolerability concerns." Perking up after 1:25 Reverse...

Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX) Vaccine for Leukemia...

Dr. Don Diamond has stated, "The City of Hope is excited to license this vaccine to GeoVax (GOVX) to progress to large-scale clinical trials...

Geovax (GOVX) – City of Hope Covid Vaccine for Chronic Lymphocytic Leukemia Patients. Interview...

Explosive Interview About GeoVax's Covid vaccine with the brilliant Dr. Don J. Diamond, Ph.D., professor at City of Hope and GeoVax vaccine’s lead developer....

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Dr. Brian Koffman is extraordinary, in many ways. He’s extraordinary in the medical sense because, after twelve years of battling blood cancer, doctors can...

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

GeoVax to Host Conference Call at 4:30 PM ET GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 ATLANTA, GA, Feb....

Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million Award from Project...

Vaxart Closes $10 Million Secondary on January 16th @0.65. Vaxart Receives $9 Million Award from Barda on January 19th. Shares trades From a Low of $0.55...

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants We were having cocktails at a fancy restaurant last night with a hedge fund manager, who manages...

Latest article

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets.UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!II.Replimune (REPL) $11.23. Gains 28% in Sympathy with UniQure. We...

Adding Bavarian Nordic (BVRNY) $8.91, to Watch List.

Bavarian Nordic Lands $106 Million Contract for its Smallpox/Mpox Vaccine! Were Back for the Third Time! LIVE QUOTE PREVIOUS WRITEUPS Aug 27, 2025: Our 4th Billion Dollar Takeover!...

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...